This summer, the U.S. Department of Justice requested additional information on Alterra Mountain Co.'s planned acquisition of Arapahoe Basin, known as A-Basin, signaling the first DOJ challenge to a ski mountain merger in...more
After a turbulent year that roiled the economy, and the health care sector more than most, the Democrats emerged with control of both the White House and Congress for the first time since 2014. Business leaders and in-house...more
2/17/2021
/ Abuse of Dominance ,
Antitrust Division ,
Antitrust Immunity ,
Antitrust Litigation ,
Antitrust Provisions ,
Biden Administration ,
Biosimilars ,
CREATE Act ,
Department of Justice (DOJ) ,
Discovery Costs ,
Enforcement ,
Federal Trade Commission (FTC) ,
Generic Drugs ,
Hatch-Waxman ,
Health Care Providers ,
Health Insurance ,
Hospital Mergers ,
Hospitals ,
Intellectual Property Litigation ,
Intellectual Property Protection ,
McCarran-Ferguson Act ,
Patent Infringement ,
Patent Litigation ,
Patents ,
Pharmaceutical Industry ,
Pharmaceutical Patents ,
Physicians ,
Prescription Drugs ,
Presidential Appointments ,
Repeal ,
Research and Development ,
Reverse Payments ,
Risk Mitigation ,
Webinars